Market revenue in 2023 | USD 23.0 million |
Market revenue in 2030 | USD 43.6 million |
Growth rate | 9.6% (CAGR from 2023 to 2030) |
Largest segment | Pharmaceuticals |
Fastest growing segment | Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pharmaceuticals, Devices |
Key market players worldwide | Johnson & Johnson, Cipla Ltd DR, Sun Pharmaceutical Industries, Merck & Co Inc, Dr. Reddy’s Laboratories, Cardiff Lexington Corp, Amgen Inc, Theradome, Aurobindo Pharma, Curallux, Apira Science |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to androgenetic alopecia market will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 98.26% in 2023. Horizon Databook has segmented the Australia androgenetic alopecia market based on pharmaceuticals, devices covering the revenue growth of each sub-segment from 2018 to 2030.
Market players and research institutes are undertaking favorable initiatives to conduct research activities in the country. For instance, in March 2023, OliX Pharmaceuticals, received the Human Research Ethics Committee (HREC) approval to initiate phase 1 clinical trial of OLX72021 for the treatment of AGA in Australia.
In Australia, low-level laser therapy (LLLT) is becoming more popular and available in homes, salons, & clinical settings. The increasing adoption of laser treatment for alopecia is due to the preference for painless treatment, coupled with their minimal adverse effects, and high disposable income in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia androgenetic alopecia market , including forecasts for subscribers. This country databook contains high-level insights into Australia androgenetic alopecia market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account